Compound Radar

STAAR Surgical Company (STAA) Stock Analysis

Price $24.16
Market cap $1.21B
Next earnings Nov 11, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

59
59/100 Acceptable
  • Financial Health 70
  • Profitability 30
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 60

Why this rating?

Health 59/100 — Acceptable

Strongest Business Quality 75/100
Softest Profitability 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

STAAR Surgical Company (STAA) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates STAAR Surgical Company 59/100 (Acceptable) due to high business quality, strong revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Adequate
  • Valuation Fair

Financial highlights

Valuation

  • P/E 302
  • Forward P/E 23.6
  • PEG 0.76
  • EV/Revenue 3.04

Profitability

  • Revenue Growth 111.0%
  • Gross Margin 76.6%
  • Operating Margin 10.9%
  • Net Margin 1.1%
  • ROE 1.1%

Financial strength

  • Cash $181.49M
  • Debt $35.94M
  • Net Cash $145.55M
  • Free Cash Flow $-40.05M
  • Current Ratio 4.67

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks STAAR Surgical Company (STAA).

View Methodology & FAQ →